NDC 73309-392 - Cysteamine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-392
- Package NDCs from labels
- 73309-392-01
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2022-06-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cysteamine Hydrochloride - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2022-06-20 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-392-01 | Cysteamine Hydrochloride | 100 g in 1 JAR | POWDER | 100 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CYSTARAN | CYSTEAMINE HYDROCHLORIDE | Leadiant Biosciences, Inc. | b98ee838-ed23-42a9-93b5-72579e490fba | 2026-10-21 | Warnings, Adverse reactions | IF1B771SVB |
| CYSTADROPS | CYSTEAMINE HYDROCHLORIDE | RECORDATI RARE DISEASES, INC. | 5d2bcce3-9b89-4141-aeb7-db00449047f5 | 2025-06-06 | Warnings, Adverse reactions | IF1B771SVB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.